Phase II trials in small-cell lung cancer: shouldn't we be doing better?
- PMID: 1320130
- DOI: 10.1093/jnci/84.14.1058
Phase II trials in small-cell lung cancer: shouldn't we be doing better?
Comment in
-
Tumor-specific T-cell immunity: ready for prime time?J Natl Cancer Inst. 1992 Jul 15;84(14):1059-61. doi: 10.1093/jnci/84.14.1059. J Natl Cancer Inst. 1992. PMID: 1619675 No abstract available.
Comment on
-
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.J Natl Cancer Inst. 1992 Jul 15;84(14):1077-84. doi: 10.1093/jnci/84.14.1077. J Natl Cancer Inst. 1992. PMID: 1320131 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
